Gensight Biologics will participate to the 11th Annual World Orphan Drug & Cell&Gene Therapy Congress to be held in a virtual format from Monday 2 November to Thursday 5 November 2020.

Magali Taiel, Chief Medical Officer, will be part of a panel discussion.


Panel Discussion – Title:  Optimising clinical development strategies for gene therapies

  • Date:  Tuesday, 3 November, 2020
  • Time:  1:35pm – 3:35pm CET
  • Session:  Cell&Gene Therapy – Clinical Development